Phosphorus
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Phosphorus is a medication indicated in the treatment of hypophosphatemia.
- Generic Name
- Phosphorus
- DrugBank Accession Number
- DB14151
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 30.9738
Monoisotopic: 30.973761512 - Chemical Formula
- P
- Synonyms
- Phosphorous
- Phosphorus, elemental
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to prevent Bone loss Combination Product in combination with: Cholecalciferol (DB00169), Calcium (DB01373) ••• ••• ••••••• - Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Advanced B & T Formula Phosphorus (100 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese cation (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Silicon (0.333 mg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg) Capsule Oral Nutraceutical Corporation Not applicable Not applicable Canada Anaplex Tab Phosphorus (75.33 mg / tab) + Ascorbic acid (40 mg / tab) + Calcium (160 mg / tab) + Iodine (.05 mg / tab) + Magnesium oxide (50 mg / tab) + Nicotinamide (30 mg / tab) + Calcium pantothenate (15 mg / tab) + Potassium chloride (20 mg / tab) + Pyridoxine hydrochloride (40 mg / tab) + Vitamin A palmitate (2000 unit / tab) + Vitamin D (133.33 unit / tab) Tablet Oral Anabolic Laboratories Inc. 1975-12-31 1996-10-02 Canada BiO-LiFE Premiton Soft Capsule Phosphorus (80 mg) + Ascorbic acid (60 mg) + Calcium (104 mg) + Cholecalciferol (400 IU) + Copper (1 mg) + Cyanocobalamin (6 mcg) + Folic acid (400 mcg) + Ginseng (100 mg) + Lipoic acid (25 mg) + Magnesium (5 mg) + Manganese cation (1 mg) + Nicotinamide (20 mg) + Calcium pantothenate (10 mg) + Potassium (4 mg) + Pyridoxine (2 mg) + Riboflavin (1.6 mg) + Rutin (20 mg) + Selenium (40 mcg) + Thiamine (1.5 mg) + Vitamin A (4000 IU) + Vitamin E (14.9 IU) + Zinc (1 mg) Capsule Oral BIO-LIFE MARKETING SDN. BHD. 2020-09-08 Not applicable Malaysia BIOGROW MIN Phosphorus (2 mg) + Boron (500 mcg) + Calcium (15 mg) + Chromium (16.8 mcg) + Copper (100 mcg) + Iodine (33.5 mcg) + Iron (3 mg) + Lithium carbonate (117 mcg) + Magnesium (5 mg) + Manganese cation (700 mcg) + Molybdenum (12.6 mcg) + Nickel cation (67 mcg) + Potassium (5 mg) + Selenium (16.7 mcg) + Silicon (12.5 mcg) + Vanadium (8.5 mcg) + Zinc (2 mg) Tablet, film coated Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia BIOGROW® VITE Phosphorus (2.5 mg) + Ascorbic acid (25 mg) + Beta carotene (500 IU) + Biotin (50 mcg) + Boron (50 mcg) + Bromelains (12.5 mg) + Calcium (2.25 mg) + Cholecalciferol (200 IU) + Choline (8.5 mg) + Chromium (10 mcg) + Copper (34 mcg) + Cyanocobalamin (2 mcg) + Folic acid (125 mcg) + Inositol (1.75 mg) + Iodine (56 mcg) + Iron (2 mg) + Magnesium (1.5 mg) + Manganese cation (750 mcg) + Molybdenum (9 mcg) + Nicotinamide (10 mg) + Pancrelipase amylase (12.5 mg) + Pantothenic acid (10 mg) + Papain (12.5 mg) + Potassium (2.5 mg) + Pyridoxine (5 mg) + Riboflavin (2 mg) + Selenium (17 mcg) + Silicon (9 mcg) + Thiamine (2 mg) + Thiamine (2.5 mg) + Vanadium (4 mcg) + Vitamin A (2500 IU) + Vitamin E (15 IU) + Zinc (2 mg) Tablet Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 27YLU75U4W
- CAS number
- 7723-14-0
- InChI Key
- OAICVXFJPJFONN-UHFFFAOYSA-N
- InChI
- InChI=1S/P
- IUPAC Name
- phosphorus
- SMILES
- [P]
References
- General References
- TITCK: Megadyn Pronatal (Multivitamin) Oral Tablet [Link]
- External Links
- Human Metabolome Database
- HMDB0001315
- ChemSpider
- 4575369
- 8263
- ChEBI
- 30207
- Wikipedia
- Phosphorus
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Not Available Chronic Kidney Disease (CKD) 1 somestatus stop reason just information to hide Not Available Completed Treatment Acute Kidney Injury (AKI) 1 somestatus stop reason just information to hide Not Available Unknown Status Prevention White Spot Lesion of Tooth 1 somestatus stop reason just information to hide Not Available Unknown Status Supportive Care Secondary Hyperparathyroidism (SHPT) 1 somestatus stop reason just information to hide 4 Unknown Status Treatment X-Linked Hypophosphatemia 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, film coated Oral Tablet Capsule Tablet Oral Liquid Oral Capsule Oral Capsule, gelatin coated Oral Powder Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 5.2 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 108.291565 predictedDeepCCS 1.0 (2019) [M+H]+ 110.04523 predictedDeepCCS 1.0 (2019) [M+Na]+ 116.777725 predictedDeepCCS 1.0 (2019)
Drug created at June 28, 2018 19:42 / Updated at May 14, 2021 01:06